Comparing cofrogliptin vs. acarbose for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new pill called cofrogliptin against a standard medicine called acarbose to see which better controls blood sugar in people with type 2 diabetes who have never taken diabetes medication. It's for those managing their diabetes with diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have type 2 diabetes and have never taken any diabetes medication
- Your blood sugar levels are within a certain range (HbA1c between 7% and 9%, fasting glucose below 11 mmol/L)
- Your body mass index is between 18 and 35
- You agree to stick with your usual diet and exercise routine during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This trial tests if adding either cofrogliptin or linagliptin (two pills that help control blood sugar) to your current insulin treatment can improve diabetes control. It is for adults with type 2 diabetes whose blood sugar is still not well managed with insulin and certain other diabetes pills.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a new diabetes medicine called Enavogliflozin against an older drug, Pioglitazone, to see which works better for lowering blood sugar and improving heart health. If you have type 2 diabetes, take metformin plus another pill, and your A1C is between 7 and 10.5, this study may be an option for you.
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.